Infusion Pumps Market Future Prospects
The infusion pumps market will generate an estimated revenue of USD 18.1 billion in 2024, and it is expected to grow at a CAGR of 7.3% during 2025–2030, to reach USD 27.5 billion by 2030.
The rising prevalence of chronic diseases, increasing popularity of home infusion treatments, growing elderly population, surging cases of hospital-acquired illnesses, and technological developments are responsible for the market expansion. For instance, as per the National Cancer Institute (NCI), there will be more than 26 million cancer survivors in the U.S. by 2040. Additionally, the number of new cancer cases is expected to rise by around 30 million each year across the world.
During the COVID-19 pandemic, to prevent the virus spread, remote monitoring of patients and usage of medications were increased, which boosted the demand for infusion pumps. In addition, the FDA approved an umbrella EUA for infusion pumps and infusion pump accessories on May 13, 2020. It has been used by healthcare professionals to treat COVID-19-related complications with regulated infusions of medicines, complete parenteral nutrition, or other fluids.